Abstract
Abnormalities of the genomic region of chromosome 19q13.2–13.4 are a common occurrence in brain malignancies and contain a possible tumor suppressor gene involved in gliomas. Since abnormalities of DNA repair are associated with malignancy, we assessed DNA status of the nucleotide excision repair genes located in this area, viz. ERCC1 and ERCC2.
Radiodensitometry was used to assess gene copy number in samples obtained from brain tumor specimens from 24 patients. Nine tumors were of lower grade histology (3 pilocytic astrocytomas, 2 gangliogliomas, 4 astrocytomas); 15 tumors were pathologiclly higher grade (4 anaplastic astrocytomas, 11 glioblastomas). Tumor samples were obtained prior to radiation or chemotherapy. Abnormalities of gene copy number of ERCC1 and ERCC2 were observed in 11/24 specimens (46%). Whereas increased and decreased copy numbers were observed for ERCC1, only decreases in copy number of ERCC2 were seen. Three tumors (all lower grade) showed concurrent allelic loss of ERCC1 and ERCC2. Abnormalities of copy number for these genes were not associated with response to subsequent therapy nor survival. However, allelic loss of ERCC2 was associated with younger age at diagnosis when compared to those specimens which did not show loss. There were no significant differences between lower grade and higher grade tumors with respect to these investigations.
Abnormalities in copy number of ERCC1 and ERCC2 are common in glial tumors. Further study of this genomic region is necessary to define the importance of these observations in tumor pathophysiology and treatment.
Similar content being viewed by others
References
von Deimling A, Louis DN, von Ammon K, Peterson I, Wiestler OD, Seizinger BR: Evidence for a tumor suppressor gene on chromsome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. Canc Res 52: 4277–4279, 1992
von Deimling A, Bender B, Jahnke R, Waha A, Kraus J, Albrecht S, Wellenreuther R, Fassbender F, Nagel J, Menon AG, Louis DN, Lenartz D, Schramm J, Wiestler OD: Loci associated with malignant progression of astrocytomas: a candidate on chromosome 19q. Canc Res 54: 1397–1401, 1994
von Deimling A, Nagel J, Bender B, Lenartz D, Schramm J, Louis DN, Wiestler OD: Deletion mapping of a putative tumor suppressor gene on chromosome 19q associated with human gliomas. Int J Canc 57: 676–680, 1994
Rubio MP, Correa KM, Ueki K, Mohrenweiser HW, Gusella JF, von Deimling A, Louis DN: The putative tumor suppressor gene on chromosome 19q maps between APOC2 and HRC. Canc Res 54: 4760–4763, 1994
Barnes DE, Kodama K, Tynan K, Trask B, Cristensen M, De Jong PJ, Spurr NK, Lindahl T, Mohrenweiser HW: Assignment of the gene encoding DNA ligase I to human chromosome 19q12.2–13.3. Genomics 12: 164–166, 1992
Westerveld A, Hoeijmakers JHJ, van Duin M, de Wit J, Odijk H, Pastink A, Bootsma D: Molecular cloning of a human DNA repair gene. Nature 310: 425–429, 1984
Flejter WL, McDaniel LD, Johns D, Friedberg EC, Schultz RA: Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: involvement of the human ERCC2 DNA repair gene. Proc Natl Acad Sci USA 89: 261–265, 1992
Larminat F, Bohr VA: Role of the human ERCC1 gene in a gene-specific repair of cisplatin-induced DNA damage. Nucl Acid Res 22: 3005–3010, 1994
Lee KB, Parker RJ, Bohr V, Cornelison T, Reed E: Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3. Cardinogenesis 14: 2177–2180, 1993
Friedberg EC: DNA repair. Freeman and Company San Francisco, 1985
Parsons R, Li G-M, Longley MJ, Fang W-H, Papadopoulos N, Jen J, de la Chapelle A, Kinzler KW, Vogelstein B, Modrich P: Hypermutability and mismatch repair deficiency in RER+ cells. Cell 75: 1227–1236, 1993
Lynch HT, Drouhard T, Lanspa S, Smyrk T, Lynch P, Lynch J, Vogelstein B, Hystrom-Lahti M, Sistonen P, Peltomaki P, de la Chapelle A: Mutation of mutL homologue in a Navajo family with hereditary nonpolyposis colorectal cancer. J Natl Canc Inst 86: 1417–1419, 1994
Dabholkar M, Vionnet J, Bostick-Bruton F, Yu JJ, Reed E: Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate to response to platinum based chemotherapy. J Clin Inv 94: 703–708, 1994
Dabholkar M, Bostick-Bruton R, Reed E: ERCC1 and ERCC2 expression in fresh human tumor tissues. J Natl Cancer Inst 84: 1512–1517, 1992
Bramson J, Panasci LC: Effect of ERCC1 overexpression on sensitivity of Chinese hamster ovary cells to DNA damaging agents. Canc Res 53: 3237–3240, 1993
Feun LG, Savaraj N, Landy HJ: Drug resistance in brain tumors. J Neuroonc 20: 165–176, 1994
Abe T, Hasogawa S, Taniguchi K, Yokomiza A, Kuwano T, Ono M, Mori T, Hori S, Kohono K, Kuwano M: Possible involvement of multidrug resistance associated protein gene expression drug resistance to VCR, etoposide and adriamycin in human glioma cells. Int J Canc 58: 860–864, 1994
Daumas-Duport C, Scheithauser B, O'Fallon J, Kelly P: Grading of astrocytomas. A simple and reproducible method. Cancer 62: 2152–2165, 1988
van Duin M, de Wit J, Odijk H, Westerveld A, Yasui A, Koken MHM, Hoeijmakers JHJ, Bootsma D: Molecular characterization of the human excision repair gene ERCC1: cDNA cloning and amino acid homology with yeast repair gene RADIO. Cell 44: 913–926, 1986
Weber CA, Salazar EP, Stewart SA, Thompson LH: cDNA cloning and molecular characterization of a human nucleotide excision repair gene with high homology to yeast RAD3. EMBO J 9: 1437–1447, 1990
Bootsma D, Hoeijmakers JH: The genetic basis of Xeroderma pigmentosum. Ann Genet 34: 143–150, 1991
Tanaka K, Wood RD: Xeroderma pigmentosum and nucleotide excision repair of DNA. Trends Biochem Sci 19: 83–86, 1994
Stoppa-Lyonnet D, Aurias A: Ataxia-teiangiectasia: what impact on clinical oncology? Bull Cancer 79: 645–650, 1990
Taylor AM: Ataxia-teiangiectasia genes and predisposition to leukemia, lymphoma, and breast cancer. Br J Cancer 66: 5–9, 1992
Marx J: DNA repair comes into its own. Science 266: 728–730, 1994
Dabholkar MD, Berger MS, Vionnet JA, Egwuagu C, Silber JR, Yu JJ, Reed E: Malignant and non-malignant brain tissues differ in their mRNA expression patterns for ERCC1 and ERCC2. Canc Res, in press
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liang, B.C., Ross, D.A. & Reed, E. Genomic copy number changes of DNA repair genes ERCC1 and ERCC2 in human gliomas. J Neuro-Oncol 26, 17–23 (1995). https://doi.org/10.1007/BF01054765
Issue Date:
DOI: https://doi.org/10.1007/BF01054765